Results 111 to 120 of about 10,818 (180)

Extended field chemoradiation in M1a bladder carcinoma: A case report

Journal of Cancer Research and Therapeutics
ABSTRACT Currently, the recommended management in stage IVA bladder cancer is platinum-based chemotherapy followed by maintenance immunotherapy in those with no evidence of disease progression. Consolidative surgery may be considered in selected cases after chemotherapy.
Kannan Periasamy, Shikha Goyal, Santosh Kumar, Vigneshwaran Chandran, Rajender Kumar   +4 more
openaire   +1 more source

Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma

Scientific Reports
Lung cancer, specifically the histological subtype lung adenocarcinoma (LUAD), has the highest global occurrence and fatality rate. Extensive research has indicated that RNA alterations encompassing m6A, m5C, and m1A contribute actively to tumorigenesis,
Yu Zhang, Qiuye Jia, Fangfang Li, Xuan Luo, Zhiyuan Wang, Xiaofang Wang, Yanghao Wang, Yinglin Zhang, Muye Li, Li Bian   +9 more
doaj   +1 more source

Association of genetic variants in m1A modification core genes and neuroblastoma risk

BMC Cancer
Neuroblastoma tightly linked with genetic abnormality. The core genes responsible for RNA N1-methyladenosine (m1A) modification are critical in tumor development. Nevertheless, few reports revealed the function of m1A modification core gene polymorphisms
Susu Jiang, Siqi Dong, Yong Li, Lei Lin, Liping Chen, Wenli Zhang, Jinhong Zhu, Xinxin Zhang, Zhonghua Yang, Jiao Zhang, Jiwen Cheng, Li Li, Haixia Zhou, Suhong Li, Wenhan Yang, Jing He, Zhenjian Zhuo   +16 more
doaj   +1 more source

P2.01-074 Wait and See: A Favorable Alternative for R-M1a and S-M1a NSCLC Patients [PDF]

Journal of Thoracic Oncology, 2017
openaire   +1 more source

TRMT6/TRMT61A-mediated tRNA m¹A modification enhances protein translation and activates the IRE1α-XBP1s pathway to promote anaplastic thyroid cancer progression. [PDF]

Cell Mol Biol Lett
Ding Y, Feng Z, Chen G, Liu Y, Zhu Y, Cao K.   +5 more
europepmc   +1 more source

FUS is an N1- and N6-methyladenosine-binding protein. [PDF]

Nucleic Acids Res
Liang X, Zhao T, Dai X, Sun Y, Yuan J, Afzalpurkar S, Duong C, Yu A, Tang F, He X, Liu X, Chen X, Cao Z, Wang Y.   +13 more
europepmc   +1 more source

Identification of m1A/m6A/m5C/m7G-related genes and clusters associated with neuropathic pain. [PDF]

Front Neurol
Tan L, Gan X, Lu D, Liang Y, Fu W, Gan Z, Wang K, Tang H, Yang P.   +8 more
europepmc   +1 more source

RNA modifications in peripheral blood are associated with acute coronary syndrome. [PDF]

J Mol Cell Cardiol Plus
Sopic M, Stopa V, Munjas J, Davidović A, Vukmirović L, Cvijanović D, Milanov M, Martelli F, Bernardin F, Legrave NM, Devaux Y.   +10 more
europepmc   +1 more source

Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence. [PDF]

Clin Nucl Med
Chen SH, Cheng NM, Fan KS, Chang PH, Lee LA, Lee LA, Huang SF, Kang CJ, Shen EY, Chang KP, Wu PW, Lien KH, Fang TJ, Cheng AJ, Chang JT.   +14 more
europepmc   +1 more source

Methyladenine as a regulator of biomolecular condensation. [PDF]

Front Mol Biosci
Arsiè R, Tartaglia GG, Vabulas RM.
europepmc   +1 more source